Effect of Theta Burst Stimulation on Alcohol Cue Reactivity
The Effect of Dorsolateral Prefrontal Cortex Theta Burst Stimulation on Alcohol Cue Reactivity and Cognitive Control: a Double-blind, Sham Controlled Study of Heavy Alcohol Drinkers With a History of Alcohol Related Injury.
1 other identifier
interventional
11
1 country
1
Brief Summary
Alcohol Use Disorder (AUD) is prevalent, devastating, and difficult to treat. The intransigence of AUD is readily apparent in the Trauma Unit of Wake Forest University Baptist Hospital, wherein 23% of trauma related admissions are associated with alcohol - higher than the national average of 16%. Of these trauma related admissions, over 70% are estimated to have AUD and 41% will be likely be admitted to the trauma unit again within 5 years. While Dr. Veach (Co-Investigator) and her team in the Department of Surgery have demonstrated that a brief counseling intervention on the inpatient trauma unit can decrease morbidity and recidivism, the rates of AUD and relapse to drinking among these individuals remains very high. With a growing knowledge of the neural circuits that contribute to relapse in AUD, there is an emerging interest in developing a novel, neural-circuit specific therapeutic tool to enhance AUD treatment outcomes. This will be achieved through a double-blind, sham-controlled cohort study in heavy alcohol drinkers with a history of alcohol-related injury. The brain reactivity to alcohol cues (Incentive Salience) and cognitive performance in the presence of an alcoholic beverage cue (Cognitive Control) will be measured immediately before and after participants receive real or sham intermittent theta burst stimulation (iTBS- a potentiating form of transcranial magnetic stimulation (TMS)) to the dorsolateral prefrontal cortex (dlPFC iTBS). The goals of this pilot study are to quantify the acute effect of a single session of real or sham dlPFC iTBS on brain response to alcohol cues (Aim 1) and cognitive flexibility in the presence of an alcohol cue (Aim 2) among risky drinkers (target engagement ).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 7, 2020
CompletedFirst Posted
Study publicly available on registry
January 10, 2020
CompletedStudy Start
First participant enrolled
August 26, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 16, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 16, 2021
CompletedResults Posted
Study results publicly available
November 10, 2022
CompletedMay 19, 2023
September 1, 2022
8 months
January 7, 2020
September 8, 2022
May 17, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Behavioral Outcomes: Change in the k-Value, a Measure of Delay Discounting of Alcohol
This outcome measure rates the change in k-value, or the delay discounting value of alcohol compared at baseline vs 1 hour after the intervention. Delay discounting is the tendency to place less value on rewards that are delayed in time. K typically falls between 0.0 and 0.5, with smaller values indicating a lack of discounting and a preference for delayed rewards, and higher values indicating stronger discounting and a preference for immediate rewards.
Baseline to 1 hour after the intervention
Study Arms (2)
Real TBS to the dlPFC
EXPERIMENTALOne session of real intermittent Theta Burst Stimulation (TBS) will be delivered to the left dorsolateral prefrontal cortex (dlPFC)
Sham TBS to the dlPFC
SHAM COMPARATOROne session of sham Theta Burst Stimulation (TBS) will be delivered to the left dorsolateral prefrontal cortex (dlPFC)
Interventions
This will be delivered with the Magventure Magpro system; 600 pulses with the active sham coil (double blinded using the USB key).
This will be delivered with the Magventure Magpro system; 600 pulses with the active sham coil (double blinded using the USB key).
Eligibility Criteria
You may qualify if:
- Ages 21-65.
- Alcohol use disorder identification test score \>7
- Drink at least 20 standard sized alcohol beverage servings per week
You may not qualify if:
- Current use of prescription or illicit psychoactive drugs (except marijuana or nicotine) known to decrease seizure threshold by self-report in the last 30 days.
- Currently meets DSM-V criteria for substance use disorder for a substance other than alcohol, marijuana, or nicotine.
- Has current suicidal or homicidal ideation.
- Current breath alcohol concentration \>0.002
- Not currently at risk for withdrawal, as indicated by CIWA-Ar \>5.
- History of seizures or seizure disorder(s).
- Females of childbearing potential who are pregnant (by urine HCG), planning to become pregnant, nursing, or who are not using a reliable form of birth control.
- Any other violation of MRI/TMS safety measures.
- Unable to read and understand questionnaires, assessments, and the informed consent.
- No presence of metal objects in the head/neck.
- History of traumatic brain injury resulting in hospitalization, loss of consciousness for more than 10 minutes, and/or having ever been informed he/she has an epidural, subdural, or subarachnoid hemorrhage.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wake Forest Baptist Health Sciences
Winston-Salem, North Carolina, 27157, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Colleen A. Hanlon, Ph.D.
- Organization
- Wake Forest University School of medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Colleen Hanlon, PhD
Wake Forest University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 7, 2020
First Posted
January 10, 2020
Study Start
August 26, 2020
Primary Completion
April 16, 2021
Study Completion
April 16, 2021
Last Updated
May 19, 2023
Results First Posted
November 10, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share
No individual participant data will be shared. All data is de-identified.